1. Home
  2. NMFC vs RAPP Comparison

NMFC vs RAPP Comparison

Compare NMFC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Mountain Finance Corporation

NMFC

New Mountain Finance Corporation

HOLD

Current Price

$9.17

Market Cap

972.8M

Sector

Finance

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$26.92

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMFC
RAPP
Founded
2010
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
972.8M
1.2B
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
NMFC
RAPP
Price
$9.17
$26.92
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$10.00
$47.80
AVG Volume (30 Days)
796.7K
417.4K
Earning Date
02-25-2026
11-06-2025
Dividend Yield
14.14%
N/A
EPS Growth
N/A
N/A
EPS
0.66
N/A
Revenue
$340,877,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.84
$6.43
52 Week High
$12.05
$42.27

Technical Indicators

Market Signals
Indicator
NMFC
RAPP
Relative Strength Index (RSI) 45.71 42.60
Support Level $9.02 $26.30
Resistance Level $9.31 $28.10
Average True Range (ATR) 0.17 1.80
MACD 0.01 -0.37
Stochastic Oscillator 37.33 20.07

Price Performance

Historical Comparison
NMFC
RAPP

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: